compared the low-aggressive TM40D and highly aggressive TM40D-MD mouse mammary carcinoma cells and discovered a positive correlation between tumor-recruited CD33+ myeloid cells and the progression of human breast cancer from DCIS to IDC (60). The gene discussed is CD33; the disease is breast carcinoma.